|Officials from JW Shinyak and Johnson & Johnson pose after signing the exclusive distributorship contract.|
JW Shinyak said Friday that it has signed an exclusive distributorship contract with Johnson & Johnson (J&J) to sell Rogaine (Ingredient: minoxidil), a hair loss treatment.
Rogaine is the top-selling hair loss treatment worldwide and is also the first treatment of its kind to receive approval from the U.S. Food and Drug Administration (FDA).
The treatment is also the first foam hair loss treatment approved for sales in Korea. The foam form allows users to apply the proper amount to only the necessary part and is also easily absorbed by the scalp and dries faster than conventional hair loss treatments.
The main ingredient, minoxidil, increases blood flow to the scalp, which in turn makes hair follicle healthy and lengthens hair growth cycle. This product also does not contain propylene glycol (PG) making it is less irritating to the scalp.
“The biggest advantage of Rogaine foam is that it can relieve the discomfort caused by liquid and gel forms,” a company JW신약 official said. “The company plans to further strengthen its position in the hair loss clinic areas through synergy with Rogaine and the company’s existing oral hair loss treatment.”
Patients can purchase Rogaine at local pharmacies.
<© Korea Biomedical Review, All rights reserved.>